Cleared Traditional

CARDIO-PAGER SYSTEM (K973527) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K973527 · Data Critical Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1998
Decision
194d
Days
Class 2
Risk

K973527 is an FDA 510(k) clearance for the CARDIO-PAGER SYSTEM. Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Data Critical Corp. (Redmond, US). The FDA issued a Cleared decision on March 31, 1998 after a review of 194 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Data Critical Corp. devices

Submission Details

510(k) Number K973527 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 18, 1997
Decision Date March 31, 1998
Days to Decision 194 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
69d slower than avg
Panel avg: 125d · This submission: 194d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 42
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K973527.
DATEX-OHMEDA NETWORK AND ICENTRAL '05, SALES REVISION 4.3
K052972 · Ge Healthcare · Dec 2005
DATEX-OHMEDA S/5 DEVICE INTERFACING SOLUTION
K051634 · Ge Healthcare · Jul 2005
INFINITY EXPLORER
K030615 · Siemens Medical Solutions USA, Inc. · Mar 2003
HEWLETT-PACKARD M2605A VIRIDIA WAVE VIEWER
K974567 · Hewlett-Packard Co. · Jan 1998